Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Research Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) on Bullrun: market cap HKD 21.62B, P/E 7.6, dividend yield 6.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0874.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyHKD
- Market capHKD 21.62B
- P/E7.6
- Dividend yield6.6%
- Financial periodQ2 2026
- RevenueCNY 18.81B
- Net incomeCNY 312.16M
- Free cash flowCNY 1.65B
- Gross margin13.5%
Valuation Snapshot
latest market cap is HKD 21.62B; P/E is 7.6; dividend yield is 6.6%.
Peer valuation comparison
Latest P/E is 7.56x versus a Healthcare sector median of 21.69x (65.2% below).
Latest dividend yield is 6.58% versus a Healthcare sector median of 2.41% (173.0% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 21.62B | 7.6 | 6.5% | 0.86 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.86 HKD, yield 6.6%.
About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's market cap?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's market capitalization is HKD 21.62B.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's P/E ratio?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's price-to-earnings (P/E) ratio is 7.6.
Does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited pay a dividend?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has a dividend yield of 6.6%.
What does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited do?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments.